Search results
Results from the Health.Zone Content Network
Johnson & Johnson ( J&J) is an American multinational, pharmaceutical, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the ...
The Janssen COVID‑19 vaccine is used to provide protection against infection by the SARS-CoV-2 virus in order to prevent COVID‑19 in people aged eighteen years and older. [37] [1] The vaccine is given by intramuscular injection into the deltoid muscle. The initial course consists of a single dose.
Jennifer Taubert. Number of employees. 45.000. Parent. Johnson & Johnson. Website. www.janssen.com. Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen .
Johnson & Johnson is ... was an area that was somewhat unreliable or unpredictable many years ago, and certainly, it was slower growth. In 2017 our growth was 1.5%, last year we enjoyed 7.8% ...
In medical technologies, J&J's major franchises include interventional solutions, orthopedics, surgery, and vision. [1] Heart and Cardiac. Abiomed. Ear, nose and throat ( Acclarent ) Eustachian Tube Balloon Dilation System [2] Navigation Balloon Dilation System [3] Cardiac Arrhythmia Diagnosis & Treatment Products (Biosense Webster)
Shockwave Medical Inc., which is based in Santa Clara, California, climbed more than $5 to $325.50. Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for ...
A subsidiary of Johnson & Johnson is now proposing to pay approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc ...
Alex Gorsky (born 1960) is an American businessman. He is the former chairman and CEO of Johnson & Johnson. Gorsky stepped down as CEO of Johnson & Johnson in January 2022 and was succeeded by Joaquin Duato. He was the seventh person who served as the company's chairman and chief executive officer since it became a publicly traded company in 1944.